CliffBio

BioDelivery Sciences International

Patent cliffs & loss of exclusivity

A pharmaceutical company focused on the development for the treatment of pain and addiction

Company

AngelList URLhttps://angel.co/biodelivery-sciences-international
CAGE Code548Q3
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/biodelivery-sciences-international
Facebook URLhttps://www.facebook.com/BioDeliverySI
Full Address100 Saw Mill Road, Danbury, CT 06810, US
LinkedIn URLhttp://www.linkedin.com/company/biodel-inc.?trk=tyah&trkInfo=tarId%3A1401451516016%2Ctas%3ABiodel%2Cidx%3A2-1-2
Previous NameMAS ACQUISITION XXIII CORP

11 upcoming patent cliffs

DrugIngredientTypeCliff
  1. BELBUCABUPRENORPHINE HYDROCHLORIDESmall mol.Dec 2032
  2. BELBUCABUPRENORPHINE HYDROCHLORIDESmall mol.Dec 2032
  3. BELBUCABUPRENORPHINE HYDROCHLORIDESmall mol.Dec 2032
  4. BELBUCABUPRENORPHINE HYDROCHLORIDESmall mol.Dec 2032
  5. BELBUCABUPRENORPHINE HYDROCHLORIDESmall mol.Dec 2032
  6. BELBUCABUPRENORPHINE HYDROCHLORIDESmall mol.Dec 2032
  7. BELBUCABUPRENORPHINE HYDROCHLORIDESmall mol.Dec 2032
  8. SYMPROICNALDEMEDINE TOSYLATESmall mol.May 2033
  9. BUNAVAILBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.Apr 2035
  10. BUNAVAILBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.Apr 2035
  11. BUNAVAILBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.Apr 2035

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

BioDelivery Sciences International — patent cliffs & loss of exclusivity | CliffBio